Ascorbic acid serum levels are reduced in patients with hematological malignancies.
about
Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine.Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells.Symposium on Vitamin C, 15th September 2017; Part of the Linus Pauling Institute's 9th International Conference on Diet and Optimum Health.Ascorbate regulates haematopoietic stem cell function and leukaemogenesis.Influence of Vitamin C on Lymphocytes: An Overview.Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our KnowledgeVitamin C and immune cell function in inflammation and cancerImpaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy
P2860
Q37264298-56BEAA03-430D-4D26-B6F5-4635B902CC99Q38668222-29453678-CB0F-491B-A774-A085C55EF3BCQ47115251-8CE07A43-9D66-45DC-8D06-85DB51D737C9Q51804038-55F76D3E-4E1D-4653-87AB-E430136B2059Q52726853-3AA8FC75-7E14-4CDC-A3F8-C4BA1A6B932FQ57167790-922CD6D9-FB9F-4D03-863D-354DCC59C904Q57293427-31A3E5CF-DC0E-4EC9-AE14-0A7A71036281Q58776882-624C3660-E209-4BB5-9E6F-432A113BB226
P2860
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@ast
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@en
type
label
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@ast
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@en
prefLabel
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@ast
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@en
P2093
P2860
P1476
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
@en
P2093
Gerard M J Bos
Mateusz Walczak
Mirelle J A J Huijskens
Wilfred T V Germeraad
Will K W H Wodzig
P2860
P356
10.1016/J.RINIM.2016.01.001
P577
2016-01-12T00:00:00Z